Grail Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference The company's preliminary fourth quarter 2021 revenues grew 25 percent, year over year, while full-year revenues grew 39 percent. Grail Partners With Premier's PINC AI to Improve Patient Access to Blood-Based Multi-Cancer Test PINC AI plans to adapt its clinical decision support platform to alert clinicians to patients who may benefit from early cancer detection via Galleri. Oncology Opportunities Provide 'Pot of Gold at the End of the Double Rainbow' for Illumina Premium Illumina is seeing continued strength in its core next-generation sequencing business as the firm is officially bringing Grail on board. Illumina Q3 Revenues Grow 40 Percent Following the closing of its purchase of Grail in August, the company is reporting consolidated results as well as separate results for its core business and Grail. European Commission Adopts Interim Measure to Hold Grail Separate From Illumina The measures are legally binding for both Illumina and Grail, and compliance with them will be monitored by a trustee to be approved by the commission. Oct 15, 2021 People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More Sep 20, 2021 European Commission Objects to Illumina Pushing Through Grail Purchase, Mulls Response Sep 20, 2021 Grail Gets NY State Department of Health Approval for Galleri Multicancer Test Aug 25, 2021 US Federal Trade Commission Begins Making the Case for Unwinding Illumina's Grail Purchase Premium Aug 20, 2021 European Commission to Investigate Illumina for Closing Grail Deal Aug 19, 2021 Illumina's 'Maverick' Move Secures Grail Deal But Risks Loom Premium Aug 18, 2021 Illumina Acquires Grail Despite Ongoing Regulatory Scrutiny Aug 12, 2021 EU Regulators Change Deadline for Illumina-Grail Investigation Jul 22, 2021 European Commission Opens In-Depth Investigation of $8B Illumina-Grail Merger Jul 21, 2021 M&A in Genomics/MDx Sector Surges in H1 2021 Premium Jun 4, 2021 Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data Premium Apr 29, 2021 Illumina Challenges European Commission's Jurisdiction Over Review of Grail Acquisition in EU General Court Apr 20, 2021 European Union to Review Illumina's Planned Grail Acquisition Under New Guidance Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Apr 2, 2021 Illumina Parries FTC Challenge to Grail Acquisition With Deals for Competing Customers Premium Mar 31, 2021 Illumina Upgraded to Buy by Canaccord Genuity Mar 30, 2021 FTC Moves to Block Illumina's $8B Grail Acquisition Feb 23, 2021 Grail Signs on Quest Diagnostics to Provide Phlebotomy for Cancer Detection Test Jan 11, 2021 Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021 Premium Jan 11, 2021 Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development Load More Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.